Nick Reaver predicts that new AI-driven healthcare companies have a two to three-year window to establish a unique data asset or workflow integration before their technology becomes commoditized.

Nick Reaver predicts that the vast majority of healthcare expenditures will remain in procedures and drugs for at least 10 more years before robotic automation becomes significant.

Nick Reaver observed a four-fold difference in complication rates, hospitalization rates, and adherence to clinical procedures depending on the individual doctor a patient was seeing.

A hospital system told Oscar Health that its lowest-performing doctors were also its highest revenue generators and were necessary to "keep the lights on."

Running a query to identify which doctors perform physical therapy before surgery across 100 billion healthcare records is a significant technical challenge.

For routine procedures like a knee replacement, the main campus of an academic medical center does not provide meaningfully better care than a local community hospital.

An estimated 10% to 30% of U.S. healthcare systems are beginning to recognize the need to compete on quality and cost to remain viable in the long term.

When Oscar Health presented data to a hospital system partner showing that one-third of its doctors were lowering patient life expectancy, the hospital refused to take action against them.

Garner Health has aggregated a dataset covering 320 million patients, primarily consisting of their full healthcare journeys in claims data.

Garner Health now controls 1% to 2% of total U.S. healthcare volume.

Value-based care models are effective in Medicare Advantage because patients individually select their plans, forcing providers to compete for patient volume.

As of mid-2024, people are using AI for primary care interactions more than they are using humans.

The total cost for a knee replacement in New York City can differ by $30,000 between the top and bottom quartile of providers.

Garner Health now represents 3-5% of patient volume in several markets, enough to fill the patient panel for a new high-quality, low-cost provider.

Unnecessary echocardiograms have a false positive rate of approximately 25%, which can lead to a cascade of further unnecessary and potentially harmful procedures.

Some large hospitals are now using Garner Health's data to inform physician compensation and benchmarking.

Garner Health announced a Series E funding round led by Index Ventures, valuing the company at approximately $2.7 billion.

Approximately 50% of members on a health plan that includes Garner Health use the tool annually, an engagement rate about 10 times higher than typical insurance directories.